FDA Seeks Public Input on Repurposing Approved Drugs
The FDA is seeking input on repurposing approved drugs for new uses. The agency aims to use existing data to speed up treatments for various medical conditions.
Xurve View
Xurve View
The United States Food and Drug Administration (FDA) is seeking public input to repurpose approved drugs for new disease indications and patient populations. The initiative aims to accelerate treatment availability by leveraging existing clinical data from previously authorized medications.
